Testing the Cog-Fun Aging Program for Older Adults with Subjective Cognitive Decline

Hebrew University of Jerusalem

Status: Enrolling

Conditions: Subjective Cognitive Impairment; Subjective Cognitive Decline (SCD); Subjective Memory Complaints

Treatments: Other: Cog Fun Ageing intervention; Other: Cog-Fun Aging Crossover

Study type: Interventional

Funder types: Other

Identifiers

NCT06816797

20112024

Details and patient eligibility

About

The goal of this clinical trial is to learn if the Cog-Fun Aging program helps older adults with Subjective Cognitive Decline (SCD) manage memory challenges and improve their daily lives. The main questions it aims to answer are:

• Does the program help participants better understand their cognitive challenges in daily life?
• Do participants report using more effective strategies to manage their memory difficulties?
• Does the Cog-Fun Aging program reduce negative emotions and self-perceptions related to SCD?

Researchers will compare participants who complete the Cog-Fun Aging program with those who do not to determine the program's effectiveness.

Participants will:

Take part in a 10-week program with weekly sessions. Learn about SCD and how it affects daily life. Practice and monitor strategies to manage memory difficulties.

Enrollment: 40 estimated patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• experiencing memory changes and feeling concerned about them
• a score of 23 or higher on the MoCA (Montreal Cognitive Assessment)
• ability to speak and understand Hebrew sufficiently to participate in a Hebrew-speaking group

Exclusion criteria

• a self-reported health condition that significantly impacts functioning (e.g., uncontrolled diabetes, severe heart/lung disease)
• residing in a medical institution or nursing home
• currently participating in another SCD treatment

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Crossover control group

Experimental group

Description:

Participants in the control arm will not receive the Cog-Fun Aging intervention during the initial phase (10 weeks). Instead, they will undergo baseline assessments (T0) alongside the intervention group. After the first group completes the 10-week program, the control arm participants will be assessed again (T1). They will then begin the 10-week Cog-Fun Aging intervention and complete a final assessment (T2) after the intervention to evaluate its effects.

Treatment:

Other: Cog-Fun Aging Crossover

Cog-Fun aging intervention

Experimental group

Treatment:

Other: Cog Fun Ageing intervention